Close

Techno Trends

Partnerships & Innovation Drive Concepts in Biotherapeutics

It is a known fact that defining the next generation of anything is a challenge. Firstly, whatever the present generation is of the topic in question has to be identified, and then the limitations as well as challenges of...

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry because of regulatory changes in Europe that are meant to make drugs safer, more effective, and last longer. Specialised excipients and active pharmaceutical ingredients (APIs), which are important parts of...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the discovery of novel molecules.   Advances in specialty intermediates, which are essential for repurposing...

AI in Specialty Chemicals is Advancing Innovation

The pharmaceutical specialty chemical industry is in the process of a seismic upheaval, powered by the revolutionary potential of artificial intelligence (AI). With its ability to read through huge sets of data, recognize patterns, and automate functions, AI in...

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation with chemical synthesis is shown to be creative in the realm of pharmaceutical manufacturing.  Following industry sustainability and innovation goals, this modern approach raises manufacturing process efficiency.  Businesses, researchers, and...

Thermo Fisher Partners with X-ELIO for Renewable Energy

Thermo Fisher Scientific has taken a significant step toward achieving its sustainability goals by signing a 10-year virtual power purchase agreement (VPPA) with renewable energy developer X-ELIO. This agreement supports the Lorca solar project, which is set to become...

Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights

The global cancer diagnostics market, valued at USD 163.7 billion in 2021, is anticipated to witness substantial growth, reaching over USD 335.7 billion by 2031, with a projected compound annual growth rate (CAGR) of 7.4% from 2022 to 2031. Analysts...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read